News
Publication Alert:Retrospective, Non-Interventional, Multicenter Study on the Effectiveness and Safety of Intravesical Bacillus Calmette–Guerin in Patients with Non-Muscle-Invasive Bladder Cancer: Real-World Experience from Six Hospital Centers in Greece
We are delighted to share our latest real-world evidence publication, titled "Retrospective, Non-Interventional, Multicenter Study on the Effectiveness and Safety of Intravesical Bacillus Calmette–Guerin in Patients with Non-Muscle-Invasive Bladder Cancer: Real-World...
Excited to Have Been Part of ISPOR conference 2024 in Barcelona, Spain!
Delighted to have been part of ISPOR—The Professional Society for Health Economics and Outcomes Research in Barcelona, Spain! Health Through Evidence proudly presented 15 research posters at ISPOR Europe 2024, highlighting impactful studies in Health Economics, Real...
Health Through Evidence will be participating in the upcoming ISPOR – Europe 2024 conference!
We are excited to announce that Health Through Evidence will be participating in the upcoming ISPOR – International Society for Pharmaceutical Outcomes Research – Europe 2024 conference in Barcelona from 17-20 November! Health Through Evidence will be presenting 15...
Publication Alert: Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Greece
Happy to share our most recent, open-access publication ”Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Greece ” in Vaccines (Impact Factor:5.2). Given the significant...
World Inflammatory Bowel Disease Day
Today, 19 May, we observe World Inflammatory Bowel Disease (IBD) Day, a day dedicated to raising awareness and understanding of this chronic condition that affects millions globally. IBD, which includes Crohn's disease and ulcerative colitis, presents significant...